FindTrial
Sign In

A study comparing ratio of systolic movement of tricuspid valve & systolic pressure of pulmonary artery, and individual parameters separately, a factor for prognosis in patients undergoing mitral valve replacement surgery

EVALUATION OF TAPSE TO PASP RATIO AS A PROGNOSTIC FACTOR IN COMPARISON WITH THE INDIVIDUAL PARAMETERS IN PATIENTS UNDERGOING MITRAL VALVE REPLACEMENT SURGERY

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/06/054172
Enrollment
60
Registered
2023-06-20
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: I059- Rheumatic mitral valve disease, unspecified

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

IPGME&R and SSKM Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Mitral stenosis and/or mitral regurgitation 2. Patients requiring mitral valve replacement as per ACC/AHA guidelines

Exclusion criteria

Exclusion criteria: 1. patient refusal 2. other cardiac ischemic and congenital lesions 3. severe AS or AR 4. severe COPD 5. CKD requiring dialysis 6. HOCM, pericardial effusion or infective endocarditis 7. emergency surgery 8. significant arrhythmias

Design outcomes

Primary

MeasureTime frame
Time to extubationTimepoint: Hours after shifting to ICU (4-24 hours)—

Secondary

MeasureTime frame
Inotrope usedTimepoint: First 24 hours after shifting to ICU;time to discharge from ICUTimepoint: Time in days after shifting to ICU—

Countries

India

Contacts

Public ContactChaitali Sen

IPGME&R and SSKM Hospital

chaitali03@rediffmail.com9330483007

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026